| Overview |
| bsm-62898r-percp-cy7-100ul |
| MALT1 Recombinant Monoclonal Antibody, PerCP-Cy7 Conjugated |
| WB, FCM, IF(ICC) |
| Human |
| Specifications |
| PerCP-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human MALT1 |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 10892 |
| Q9UDY8 |
| Cytoplasm, Nucleus |
| Malt1; MLT1; Mucosa associated lymphoid tissue lymphoma translocation gene 1; Paracaspase. |
| Protease that enhances BCL10-induced activation: acts via formation of CBM complexes that channel adaptive and innate immune signaling downstream of CARD domain-containing proteins (CARD9, CARD11 and CARD14) to activate NF-kappa-B and MAP kinase p38 pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IF(ICC) |
1:50-200 |
Powered by Bioz